Hortensius Lisa M, van Elburg Ruurd M, Nijboer Cora H, Benders Manon J N L, de Theije Caroline G M
Department of Neonatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Front Physiol. 2019 Jul 26;10:961. doi: 10.3389/fphys.2019.00961. eCollection 2019.
Preterm infants are at high risk for Encephalopathy of Prematurity and successive adverse neurodevelopmental outcome. Adequate nutrition is crucial for healthy brain development. Maternal breast milk is first choice of post-natal enteral nutrition for preterm infants. However, breast milk contains insufficient nutrient quantities to meet the greater nutritional needs of preterm infants, meaning that supplementation is recommended. To provide an overview of current literature on potential nutritional interventions for improvement of neurodevelopmental outcome in preterm infants, by taking a bench to bedside approach from pre-clinical models of neonatal brain injury to randomized controlled clinical trials (RCTs) in preterm infants. Separate clinical and pre-clinical searches were performed in Medline and Embase for English written papers published between 08/2008 and 08/2018 that studied a single nutritional component. Papers were included if one of the following components was studied: lipids, carbohydrates, proteins, vitamins, minerals, probiotics, prebiotics, oligosaccharides, fatty acids, or amino acids, with brain injury, brain development or neurodevelopmental outcome as outcome measure in preterm infants (gestational age <32 weeks and/or birth weight <1,500 g) or in animal models of neonatal brain injury. In total, 2,671 pre-clinical studies and 852 RCTs were screened, of which 24 pre-clinical and 22 RCTs were included in this review. In these trials supplementation with amino acids and protein, lipids, probiotics (only clinical), prebiotics (only clinical), vitamins, and minerals was studied. All included pre-clinical studies show positive effect of supplementation on brain injury and/or neurodevelopment. Although some nutrients, such as glutamine, show promising short term outcome in clinical studies, no evident long term effect of any supplemented nutrient was found. Main limitations were inclusion of studies no older than 10 years at time of search and studies that focused on single nutritional components only. Even though many pre-clinical trials demonstrate promising effects of different nutritional interventions on reducing brain injury and/or improving neurodevelopmental outcome, these positive effects have so far not evidently been demonstrated in RCTs. More clinically relevant animal models and long term follow up after clinical trials are needed to move novel nutritional therapies from bench to bedside of preterm infants.
早产儿发生早产性脑病及后续不良神经发育结局的风险很高。充足的营养对健康的大脑发育至关重要。母乳是早产儿出生后肠内营养的首选。然而,母乳所含的营养量不足以满足早产儿更高的营养需求,这意味着建议进行营养补充。为了概述当前关于改善早产儿神经发育结局的潜在营养干预措施的文献,采用从新生儿脑损伤的临床前模型到早产儿随机对照临床试验(RCT)的从实验室到临床的方法。在Medline和Embase中分别进行临床和临床前检索,以查找2008年8月至2018年8月期间发表的研究单一营养成分的英文论文。如果研究了以下成分之一,则纳入论文:脂质、碳水化合物、蛋白质、维生素、矿物质、益生菌、益生元、低聚糖、脂肪酸或氨基酸,以脑损伤、脑发育或神经发育结局作为早产儿(胎龄<32周和/或出生体重<1500克)或新生儿脑损伤动物模型的结局指标。总共筛选了2671项临床前研究和852项RCT,其中24项临床前研究和22项RCT纳入了本综述。在这些试验中,研究了氨基酸和蛋白质、脂质、益生菌(仅临床研究)、益生元(仅临床研究)、维生素和矿物质的补充。所有纳入的临床前研究均显示补充对脑损伤和/或神经发育有积极作用。虽然一些营养素,如谷氨酰胺,在临床研究中显示出有希望的短期结局,但未发现任何补充营养素的明显长期效果。主要局限性在于纳入的研究在检索时不超过10年,且研究仅关注单一营养成分。尽管许多临床前试验证明了不同营养干预措施对减少脑损伤和/或改善神经发育结局有有希望的效果,但这些积极效果迄今为止在RCT中尚未得到明显证实。需要更多与临床相关的动物模型和临床试验后的长期随访,以便将新的营养疗法从实验室应用到早产儿的临床中。